MedPath

Randomized controlled trial of Jinkui Zexie Decoction in the treatment of benign paroxytic positional vertigo

Phase 3
Conditions
benign paroxytic positional vertigo
Registration Number
ITMCTR2100005043
Lead Sponsor
China Academy of Chinese Medical Scicences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Aged 18 to 65 years, with normal behavior;
2. Meet the diagnostic criteria, of which the TCM diagnostic criteria must be determined by two senior TCM physicians based on syndrome differentiation;
3. The Chinese version of the Vertigo Disability Assessment Scale (DHI) score, E value>18 points;
4. The study was ethically reviewed, and all the enrolled patients signed the informed consent.

Exclusion Criteria

1. Brain trauma stroke; blood disease stroke; severe rheumatic heart disease complicated with atrial fibrillation;
2. Combined with cervical spine, craniocerebral space-occupying lesions, liver and kidney system diseases; mental illness;
3. Pregnancy;
4. Those who are allergic to drugs;
5. Cases of taking other traditional Chinese medicines (including decoctions, proprietary Chinese medicines, etc.) at the same time.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Vertigo Disability Rating Scale Score;
Secondary Outcome Measures
NameTimeMethod
Clinical symptom evaluation scale score of vertigo;
© Copyright 2025. All Rights Reserved by MedPath